Illustrative image – not actual.
Omnicare Drugs India, a wholly-owned subsidiary of UAE-based Neopharma and ASKA Pharmaceuticals Company, Tokyo, has entered an agreement to set up a pharmaceutical manufacturing joint venture in Visakhapatnam, Andhra Pradesh.
The pharma plant will entail an investment of Rs 350 crore. The facility will manufacture oral solid dosage forms, oral liquids and topical preparations. It will have a capacity of three billion tablets.
The plant will be based at J N Pharma city. The work on the plant is expected to begin by May 2018 and is proposed to establish by 2020.
